{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T20:18:21Z","timestamp":1768421901881,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T00:00:00Z","timestamp":1557360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jmii.2019.04.008","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T03:05:28Z","timestamp":1557803128000},"page":"788-795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Comparative efficacy of doripenem versus meropenem for hospital-acquired and ventilator-associated pneumonia"],"prefix":"10.1016","volume":"52","author":[{"given":"Wang-Da","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8610-5916","authenticated-orcid":false,"given":"Ming-Chieh","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chung","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jann-Tay","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang-Huei","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2019.04.008_bib1","doi-asserted-by":"crossref","first-page":"219e223","DOI":"10.1016\/0002-9343(80)90357-5","article-title":"Deaths from nosocomial infections: experience in a university hospital and a community hospital","volume":"68","author":"Gross","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.jmii.2019.04.008_bib2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1164\/ajrccm.165.7.2105078","article-title":"Ventilator-associated pneumonia","volume":"165","author":"Chastre","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jmii.2019.04.008_bib3","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1097\/CCM.0b013e3182281f33","article-title":"Estimating the attributable mortality of ventilator-associated pneumonia from randomized prevention studies","volume":"39","author":"Melsen","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jmii.2019.04.008_bib4","first-page":"464","article-title":"Attributable mortality of ventilator-associated pneumonia","volume":"17","author":"Timsit","year":"2011","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.jmii.2019.04.008_bib5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/664049","article-title":"Economic impact of ventilator-associated pneumonia in a large matched cohort","volume":"33","author":"Kollef","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jmii.2019.04.008_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00151829-200403020-00006","article-title":"Hospital-acquired pneumonia in critically ill patients: mortality risk stratification upon onset","volume":"3","author":"Leroy","year":"2004","journal-title":"Treat Respir Med"},{"key":"10.1016\/j.jmii.2019.04.008_bib7","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.ajic.2007.05.011","article-title":"Epidemiology, etiology, and diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia in Asian countries","volume":"36","author":"Chawla","year":"2008","journal-title":"Am J Infect Contr"},{"key":"10.1016\/j.jmii.2019.04.008_bib8","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.chest.2016.04.009","article-title":"A case\u2013control study assessing the impact of nonventilated hospital-acquired pneumonia on patient outcomes","volume":"150","author":"Micek","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jmii.2019.04.008_bib9","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jmii.2017.11.001","article-title":"National bundle care program implementation to reduce ventilator-associated pneumonia in intensive care units in Taiwan","volume":"52","author":"Kao","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2019.04.008_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bjid.2016.03.004","article-title":"The effectiveness of a bundle in the prevention of ventilator-associated pneumonia","volume":"20","author":"Ferreira","year":"2016","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jmii.2019.04.008_bib11","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/CCM.0000000000003136","article-title":"Ventilator bundle and its effects on mortality among ICU Patients: a meta-analysis","volume":"46","author":"Pileggi","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jmii.2019.04.008_bib12","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jmii.2013.09.007","article-title":"Efficacy of ventilator-associated pneumonia care bundle for prevention of ventilator-associated pneumonia in the surgical intensive care units of a medical center","volume":"48","author":"Lim","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2019.04.008_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/dkn162","article-title":"Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy","volume":"62","author":"Masterton","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2019.04.008_bib14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/1756-0500-7-232","article-title":"Nosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: a retrospective review and analysis","volume":"7","author":"Behnia","year":"2014","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jmii.2019.04.008_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jhin.2015.11.013","article-title":"Diagnosis and features of hospital-acquired pneumonia: a retrospective cohort study","volume":"92","author":"Russell","year":"2016","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jmii.2019.04.008_bib16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ajic.2011.05.020","article-title":"International nosocomial infection control Consortium (INICC) report, data summary of 36 countries, for 2004\u20132009","volume":"40","author":"Rosenthal","year":"2012","journal-title":"Am J Infect Contr"},{"key":"10.1016\/j.jmii.2019.04.008_bib17","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1164\/rccm.201102-0349OC","article-title":"High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia","volume":"184","author":"Chung","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jmii.2019.04.008_bib18","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical Practice Guidelines by the infectious diseases society of America and the American thoracic society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2019.04.008_bib19","first-page":"176","article-title":"Multidrug-resistant Gram-negative bacterial infections: the emerging threat and potential novel treatment options","volume":"9","author":"Vergidis","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.jmii.2019.04.008_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jmii.2017.08.015","article-title":"Risk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosa","volume":"51","author":"Tsao","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2019.04.008_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jmii.2017.08.001","article-title":"Clonal spread of carbapenem-resistant Acinetobacter baumannii across a community hospital and its affiliated long-term care facilities: a cross sectional study","volume":"51","author":"Chen","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2019.04.008_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jmii.2016.06.007","article-title":"Effects of implementation of an online comprehensive antimicrobial-stewardship program in ICUs: a longitudinal study","volume":"51","author":"Chen","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2019.04.008_bib23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/CCM.0b013e31826ab4c4","article-title":"Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility","volume":"41","author":"Roberts","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jmii.2019.04.008_bib24","series-title":"The Sanford Guide to antimicrobial Therapy 2015","author":"Gilbert","year":"2015"},{"key":"10.1016\/j.jmii.2019.04.008_bib25","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1128\/AAC.48.8.3136-3140.2004","article-title":"Activities of doripenem (S-4661) against drug-resistant clinical pathogens","volume":"48","author":"Jones","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2019.04.008_bib26","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/CCM.0b013e3181691b99","article-title":"Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study","volume":"36","author":"Chastre","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jmii.2019.04.008_bib27","doi-asserted-by":"crossref","first-page":"R218","DOI":"10.1186\/cc11862","article-title":"A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia","volume":"16","author":"Kollef","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.jmii.2019.04.008_bib28","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1185\/03007990802179255","article-title":"Efficacy and safety of doripenem versus piperacillin\/tazobactam in nosocomial pneumonia: a randomized, open label, multicenter study","volume":"24","author":"R\u00e9a-Neto","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jmii.2019.04.008_bib29","author":"US Food and Drug Administration (FDA)"},{"key":"10.1016\/j.jmii.2019.04.008_bib30","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1093\/jac\/dkq334","article-title":"Efficacy of doripenem in the treatment of Pseudomonas aeruginosa experimental pneumonia versus imipenem and meropenem","volume":"65","author":"Bretonni\u00e8re","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2019.04.008_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jiac.2015.11.011","article-title":"Clinical efficacy and safety of high-dose doripenem in Japanese patients with pneumonia","volume":"22","author":"Yatera","year":"2016","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jmii.2019.04.008_bib32","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1345\/aph.1R097","article-title":"Pharmacokinetics and Monte Carlo simulations of doripenem in patients with febrile neutropenia","volume":"46","author":"Stein","year":"2012","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jmii.2019.04.008_bib33","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1592\/phco.31.4.408","article-title":"Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations","volume":"31","author":"Miller","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jmii.2019.04.008_bib34","series-title":"Chambers HF. Other \u03b2-lactam antibiotics","first-page":"P293","article-title":"Mandell, douglas, and bennett's principles and Practice of infectious diseases","author":"Bennett","year":"2015"},{"key":"10.1016\/j.jmii.2019.04.008_bib35","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/jac\/dku111","article-title":"The risk of seizures among the carbapenems: a meta-analysis","volume":"69","author":"Cannon","year":"2014","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118219300453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118219300453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:24:08Z","timestamp":1761657848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118219300453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1684118219300453"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2019.04.008","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy of doripenem versus meropenem for hospital-acquired and ventilator-associated pneumonia","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2019.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}